Press Releases

2022

Scientists Put CRISPR on Safer Path to Patient Treatments with New Process for Evaluating Impacts of Gene Edits that Alter Rather than “Knock Out” DNA Code

In a new study in journal Gene Therapy, researchers at ChristianaCare’s Gene Editing Institute describe how the advance is validating the safety and efficacy of their novel approach for using CRISPR to improve lung cancer treatments

ChristianaCare’s Gene Editing Institute brings all-female team of scientists from Delaware to teach gene editing with CRISPR in a BoxTM at all-girls high school in North Carolina

Students at Salem Academy first to learn with the innovative tool in North Carolina as interest grows nationwide

2021

ChristianaCare’s Gene Editing Institute and DETV produce video series to engage high school students in the latest biomedical technologies and encourage them to pursue scientific careers

CRISPR in a Box Educational ToolkitTM – a gene editing experiment developed by the Gene Editing Institute for teaching – and the videos are already being used in classrooms in Delaware; Goal to reach students of color

St. Georges Technical High School is first high school in the U.S. to use the Gene Editing Institute’s CRISPR in a Box Educational ToolkitTM

Toolkit is easily incorporated into any laboratory science course

Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair
Study in The CRISPR Journal from ChristianaCare’s Gene Editing Institute reports the app advances CRISPR gene therapy R&D; 18-year-old software savant helped lead the app’s development

2020

Researchers tackle sickle cell disease with CRISPR-based gene editing

$1 million grant will advance personalized medicine using gene editing at ChristianaCare’s Gene Editing Institute

Unique scientific-academic partnership advances revolutionary CRISPR in a BoxTM educational gene editing kit
Support from a second National Science Foundation grant will train next generation of scientists to find cures and therapies for diseases, including viral infections like COVID-19
New CRISPR Advance May Solve Key Quandary: How to Safely Disable Gene that Helps Cancer Tumors Evade Treatment — But Also Keeps Normal Cells Healthy
Scientists at ChristianaCare’s Gene Editing Institute use lung cancer tumor mutation as homing signal to “knock out” gene linked to “bleak prognosis” without affecting normal cells
Federal guidelines will speed bench-to-bedside research and advance clinical trials using gene editing technology
ChristianaCare and Delaware BioScience Association event explores new FDA Guidances and other challenges and opportunities in gene editing

2019

New Tool for Rapidly Analyzing CRISPR Gene Edits Reveals Frequent Production of Unintended Edits Near Site of DNA Repairs

Study in Communications Biology-Nature from ChristianaCare’s Gene Editing Institute debuts new method that unmasks all DNA changes caused by CRISPR in two days vs. two months; most errant edits may be harmless, but insights essential to gauge patient risks

Need more information?

For media inquiries, email your request to: inquiries@geneeditinginstitute.com.